In conclusion, galectin-1 shows a strong cross-sectional association with decreased kidney function, but two-sample MR analyses suggest a causal protective effect of galectin-1 on kidney function among participants with type 2 diabetes at high risk of diabetic nephropathy. The gene discussed is LGALS1; the disease is diabetic kidney disease.